FindTrial
Sign In

Effect of supplementation of chromium in glucose of diabetic patients

Effect of Supplementation of Chromium Picolinate on blood glucose with Type 2 Diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-79nxr8
Enrollment
Unknown
Registered
2014-10-08
Start date
2011-11-11
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Interventions

P1 Group: 40 patients with type-2 diabetes, poorly controlled, will ingest a capsule containing 300 micrograms of chromium picolinate, twice daily (after breakfast and dinner), during 4 months. After
Dietary supplement
J02.500.456

Sponsors

Universidade Feral do Rio Grande do Norte
Lead Sponsor
Universidade Federal do Rio Grande do Norte
Collaborator

Eligibility

Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Volunteers diagnosed with type two diabetes mellitus according to the criteria of the American Diabetes Association two thousand and eleven; both genders; presenting glycated hemoglobin greater than or equal to seven percent; not in use of insulin; age between thirty and seventy years; not have taked mineral vitamin supplement in the last three months

Exclusion criteria

Exclusion criteria: Volunteers taking insulin and / or corticosteroids; showing endocrinopathy (cushin syndrome; acromegaly; hyper or uncontrolled hypothyroidism); kidney disease; cancer; infection and anemia; pregnant women; lactating women

Design outcomes

Primary

MeasureTime frame
Improvement in glycemic control (fasting blood glucose, postprandial blood glucose and glycated hemoglobin), after 4 months of supplementation with chromium picolinate compared the differences between the groups;The glycemic profile (fasting blood glucose, postprandial blood glucose and glycated hemoglobin) showed improvement after 4 months of supplementation with chromium picolinate, compared the differences between the groups—

Secondary

MeasureTime frame
Improvement in lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides), after 4 and 8 months of supplementation with chromium picolinate compared the differences between the groups;No improvement was found in the lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides)after 4 months of supplementation with chromium picolinate, compared the differences between the groups—

Countries

Brazil

Contacts

Public ContactAna Paiva

Universidade Federal do Rio Grande do Norte

ananpaiva@gmail.com+55(84)99888377

Outcome results

None listed

Source: REBEC (via WHO ICTRP)